ArticleJournal of Cancer2024

Derived from fangchinoline, LYY-35 exhibits an inhibiting effect on human NSCLC cancer A549 cells.

Bo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.